Buprenorphine derivatives and uses thereof

Details for Australian Patent Application No. 2007231133 (hide)

International Classifications

Event Publications

25 September 2008 PCT application entered the National Phase

PCT publication WO2007/110636 Priority application(s): WO2007/110636

16 October 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 09 Sep 2008

25 August 2011 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Reckitt Benckiser (UK) Limited, Application No. 2007231133, under INID (71) correct the applicant name to read Reckitt Benckiser Healthcare (UK) Limited

1 September 2011 Application Accepted

Published as AU-B-2007231133

12 January 2012 Standard Patent Sealed

27 September 2012 Assignment Registered

Reckitt Benckiser Healthcare (UK) Limited The patent has been assigned to RB Pharmaceuticals Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.